The US Food and Drug Administration on Wednesday approved a second GLP-1 pill for weight loss, adding another option to its rapidly growing arsenal of obesity therapies. The orforglipron pill, called Foundayo, is made by Eli Lilly, which also sells the GLP-1 drugs Zepbound for obesity and Mounjaro for diabetes. It is given as a … Read more
The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more
Economists at ING have released a new report on the expected impact of appetite weight loss medications on European food demand. Insights reveal how much GLP-1 drugs will impact and reshape the industry in the coming years. GLP-1 drugs are widely discussed as potentially transformative for food consumption, but their short-term impact in 2026 is … Read more
India is expected to see a GLP-1 boom as Novo Nordisk’s semaglutide patent expires in the country this month. GLP-1s such as Wegovy and Ozempic have made a big impact in the treatment of diabetes and weight loss, especially in the US. The expiring patent marks an important moment for India’s pharmaceutical and nutritional sectors, … Read more
For many consumers, clothing is becoming more complicated, not less. Weight loss drugs reshape the body faster than it can be stored in the wardrobe. dating applications are putting new pressure on how people present themselves. And in parts of the United States, access to fashion retail is disappearing altogether. For Stitch Fix, those moments … Read more
By JONEL ALECCIA, AP Health Writer Whether they’re using a weekly shot or a daily pill, more Americans than ever are turning to anti-obesity drugs to lose weight and improve health. About 1 in 8 US adults say they take a GLP-1 drug, according to a recent survey by the health research group KFF. Just … Read more
by Emily Siner, Nashville Public Radio and Anthony’s way and Blake Farmer, Nashville Public Radio, for KFF Severe ankle pain led Jelon Smart to start weight loss injections a year and a half ago. Smart was 285 pounds and worked as a caterer in Savannah, Georgia. After he stood on his feet for hours, his … Read more
GLP-1 class weight loss drugs can help users shed tens of pounds, leading to a more active, energized life. One in eight Americans now say they are taking shots, which became popular in the US in the early 2020s. Since then, researchers have studied the benefits of additional drugs can have across several organ systems. … Read more
Your support helps us tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground as stories develop. Whether it’s investigating the finances of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which highlights American women fighting for reproductive rights, we know how important … Read more
Boston Mayor Michelle Wu said her administration had reached an agreement with the City Hall union to limit coverage of the GLP-1 drug for weight loss that would save the city about $10.6 million and reduce “skyrocketing” health care costs. Wu and the Public Employees Committee, which bids for health insurance benefits on behalf of … Read more